70 results
Page 3 of 4
PRE 14A
ff5qdv nkzcvou
22 Nov 21
Preliminary proxy
4:45pm
8-K
EX-99.1
dbjje9m8
2 Nov 21
Agile Therapeutics Reports Third Quarter 2021 Financial Results
4:11pm
8-K
EX-99.1
vhd kgwpp
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
424B5
daxp619j64
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
ks5 xddnyxrct2dq
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
iyphy6km
4 Oct 21
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
4:30pm
8-K
EX-99.1
3jknd0bp
10 Sep 21
Regulation FD Disclosure
4:31pm
8-K
y2dvg dv3
10 Sep 21
Regulation FD Disclosure
4:31pm
8-K
EX-99.1
2kyruoe vasvqfs
26 Jul 21
Agile Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
31ej9m59yg2gie3fs
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
424B5
fv3r l5na
18 Mar 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
wct7nf76bw
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
volcmi
14 Jan 21
Results of Operations and Financial Condition
8:30am
8-K
7y5bc5dljnqnlhb1qc
14 Jan 21
Results of Operations and Financial Condition
8:30am